PL360254A1 - Kompozycja farmaceutyczna - Google Patents

Kompozycja farmaceutyczna

Info

Publication number
PL360254A1
PL360254A1 PL01360254A PL36025401A PL360254A1 PL 360254 A1 PL360254 A1 PL 360254A1 PL 01360254 A PL01360254 A PL 01360254A PL 36025401 A PL36025401 A PL 36025401A PL 360254 A1 PL360254 A1 PL 360254A1
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
mum
median
particles
clavulanic acid
Prior art date
Application number
PL01360254A
Other languages
English (en)
Inventor
Stefan Horkovics-Kovats
Johannes Raneburger
Franz Xaver Schwarz
Original Assignee
Biochemie Gesellschaft M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3689001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL360254(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biochemie Gesellschaft M.B.H. filed Critical Biochemie Gesellschaft M.B.H.
Publication of PL360254A1 publication Critical patent/PL360254A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
    • C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
    • C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
    • C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL01360254A 2000-10-20 2001-10-18 Kompozycja farmaceutyczna PL360254A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT18062000 2000-10-20
PCT/EP2001/012076 WO2002032906A1 (en) 2000-10-20 2001-10-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PL360254A1 true PL360254A1 (pl) 2004-09-06

Family

ID=3689001

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01360254A PL360254A1 (pl) 2000-10-20 2001-10-18 Kompozycja farmaceutyczna

Country Status (13)

Country Link
US (1) US20040043981A1 (pl)
EP (1) EP1328528B1 (pl)
JP (2) JP2004511561A (pl)
KR (1) KR20030069995A (pl)
CN (1) CN1267437C (pl)
AT (1) ATE286057T1 (pl)
AU (1) AU2002221702A1 (pl)
CA (1) CA2424462C (pl)
DE (1) DE60108154T2 (pl)
ES (1) ES2234919T3 (pl)
MX (1) MXPA03003312A (pl)
PL (1) PL360254A1 (pl)
WO (1) WO2002032906A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7295509B2 (en) 2000-09-13 2007-11-13 Qualcomm, Incorporated Signaling method in an OFDM multiple access system
US9130810B2 (en) 2000-09-13 2015-09-08 Qualcomm Incorporated OFDM communications methods and apparatus
US9246560B2 (en) 2005-03-10 2016-01-26 Qualcomm Incorporated Systems and methods for beamforming and rate control in a multi-input multi-output communication systems
US9154211B2 (en) 2005-03-11 2015-10-06 Qualcomm Incorporated Systems and methods for beamforming feedback in multi antenna communication systems
US8446892B2 (en) 2005-03-16 2013-05-21 Qualcomm Incorporated Channel structures for a quasi-orthogonal multiple-access communication system
US9143305B2 (en) 2005-03-17 2015-09-22 Qualcomm Incorporated Pilot signal transmission for an orthogonal frequency division wireless communication system
US9520972B2 (en) 2005-03-17 2016-12-13 Qualcomm Incorporated Pilot signal transmission for an orthogonal frequency division wireless communication system
US9184870B2 (en) 2005-04-01 2015-11-10 Qualcomm Incorporated Systems and methods for control channel signaling
US9036538B2 (en) 2005-04-19 2015-05-19 Qualcomm Incorporated Frequency hopping design for single carrier FDMA systems
US9408220B2 (en) 2005-04-19 2016-08-02 Qualcomm Incorporated Channel quality reporting for adaptive sectorization
US8879511B2 (en) 2005-10-27 2014-11-04 Qualcomm Incorporated Assignment acknowledgement for a wireless communication system
US8462859B2 (en) 2005-06-01 2013-06-11 Qualcomm Incorporated Sphere decoding apparatus
US9179319B2 (en) 2005-06-16 2015-11-03 Qualcomm Incorporated Adaptive sectorization in cellular systems
US8599945B2 (en) 2005-06-16 2013-12-03 Qualcomm Incorporated Robust rank prediction for a MIMO system
US8885628B2 (en) 2005-08-08 2014-11-11 Qualcomm Incorporated Code division multiplexing in a single-carrier frequency division multiple access system
US9209956B2 (en) 2005-08-22 2015-12-08 Qualcomm Incorporated Segment sensitive scheduling
US8644292B2 (en) 2005-08-24 2014-02-04 Qualcomm Incorporated Varied transmission time intervals for wireless communication system
US9136974B2 (en) 2005-08-30 2015-09-15 Qualcomm Incorporated Precoding and SDMA support
US9210651B2 (en) 2005-10-27 2015-12-08 Qualcomm Incorporated Method and apparatus for bootstraping information in a communication system
US8477684B2 (en) 2005-10-27 2013-07-02 Qualcomm Incorporated Acknowledgement of control messages in a wireless communication system
US9225416B2 (en) 2005-10-27 2015-12-29 Qualcomm Incorporated Varied signaling channels for a reverse link in a wireless communication system
US8045512B2 (en) 2005-10-27 2011-10-25 Qualcomm Incorporated Scalable frequency band operation in wireless communication systems
US9225488B2 (en) 2005-10-27 2015-12-29 Qualcomm Incorporated Shared signaling channel
US9144060B2 (en) 2005-10-27 2015-09-22 Qualcomm Incorporated Resource allocation for shared signaling channels
US8582509B2 (en) 2005-10-27 2013-11-12 Qualcomm Incorporated Scalable frequency band operation in wireless communication systems
US9088384B2 (en) 2005-10-27 2015-07-21 Qualcomm Incorporated Pilot symbol transmission in wireless communication systems
US8693405B2 (en) 2005-10-27 2014-04-08 Qualcomm Incorporated SDMA resource management
CA2758029A1 (en) * 2009-04-29 2011-11-04 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29038A (en) * 1860-07-03 George a
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
AU3817300A (en) * 1999-04-01 2000-08-01 Dsm N.V. Agglomerates by crystallisation

Also Published As

Publication number Publication date
JP2009197020A (ja) 2009-09-03
DE60108154T2 (de) 2005-12-22
CA2424462C (en) 2010-03-30
CN1267437C (zh) 2006-08-02
KR20030069995A (ko) 2003-08-27
CA2424462A1 (en) 2002-04-25
WO2002032906A1 (en) 2002-04-25
EP1328528B1 (en) 2004-12-29
US20040043981A1 (en) 2004-03-04
DE60108154D1 (de) 2005-02-03
CN1469880A (zh) 2004-01-21
MXPA03003312A (es) 2004-12-03
AU2002221702A1 (en) 2002-04-29
ATE286057T1 (de) 2005-01-15
EP1328528A1 (en) 2003-07-23
JP2004511561A (ja) 2004-04-15
ES2234919T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
PL360254A1 (pl) Kompozycja farmaceutyczna
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
WO2001044271A3 (en) Daptomycin analogs and their use as antibacterial agents
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
WO2001092340A3 (en) Use of interleukin-4 antagonists and compositions thereof
HUP0302337A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
MY129150A (en) Novel sulfamides
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
WO2001058412A3 (de) Extrakte von rückständen aus der weinherstellung
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
AU3227700A (en) Skin sanitizing compositions
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
CA2361402A1 (en) Bis-sulfonamides
EP1311477A4 (en) NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM
ZA200405302B (en) Detergent compositions.
MY140724A (en) Novel arylethene-sulfonamides
SE0001916D0 (sv) Novel formulation
BG66081B1 (bg) Състави, съдържащи модафинилни съединения
ATE259213T1 (de) Oralreinigungsmittel
HUP0204422A3 (en) Calcium dicarboxylate ethers, methods of making the compounds, and pharmaceutical compositions containing them
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
HU9700437D0 (en) Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)